Relatively new player in the Healthcare space – they started announcing healthcare investments in early April including the distributions rights to sell Covid antibody test kits. The stock traded went from 3c to 8c after a number of healthcare related announcements. The company has since gone quiet as they are working hard to complete Covid testing kit sales in the US in order to meet their 200k target by mid-July as per their distribution agreement. Currently the SP is at 2.5c. Lots of upside to realized here at these levels.
Fundamentals: $4M market cap company with $2M in liquid assets (cash + investments)
Investments: Covid antibody kit sales, Telemedicine roll-out, Nuwave (shelf stable food), they own 30M shares in GAIA Grow
Near-term catalysts: They need to fulfill 200k test kit sales by mid-July to meet the terms of their distribution agreement. This could generate $1-2M in revenue for the company. In addition, they are pending FDA EUA and HC gov’t approvals.